With the analysis among 152 patents, we discovered top 21 key players by total patent application. X4 Pharmaceuticals, Inc., Genzyme Corp., BioLineRx Ltd. are dominant in this area. They take 65.79% of the total patent filing.
Massachusetts, United States
Patent: 65
Massachusetts, United States
Patent: 23
New Jersey, United States
Patent: 6
California, United States
Patent: 3
Massachusetts, United States
Patent: 3
Beijing Shi, China
Patent: 3
Jiangsu Sheng, China
Patent: 3
North Carolina, United States
Patent: 2
No data, please try another search term
With the analysis among related 97 patents applied in the last 5 years. We discover 11 most active companies in this area. The fast-growing X4 Pharmaceuticals, Inc., BioLineRx Ltd., GPCR Therapeutics, Inc. take 68.04% of patent filing during this period.
Massachusetts, United States
Patent: 46
Jiangsu Sheng, China
Patent: 3
Missouri, United States
Patent: 2
Basel-Landschaft, Switzerland
Patent: 2
Guangdong Sheng, China
Patent: 2
With the analysis among related 97 patents in last 5 years, we discover 7 new entrants. GPCR Therapeutics, Inc., CGeneTech (Suzhou, China) Co. Ltd., Fraunhofer-Gesellschaft eV are the most active new entrants in this area.
Jiangsu Sheng, China
Patent: 3
Missouri, United States
Patent: 2
Basel-Landschaft, Switzerland
Patent: 2
Guangdong Sheng, China
Patent: 2
With the analysis among 14 patents, we discovered top 4 universities and scientific research institutions by total patent application. Tsinghua University, Washington University in St. Louis, Hokkaido University are dominant in this area. They take 64.29% of the total patent filing.
Beijing Shi, China
Patent: 3
Missouri, United States
Patent: 2
Bretagne, France
Patent: 1